Skip to content
naulon
Not checkedNot checked for notices yet.

Investigation of graphene-coated Ag/AgCl electrode performance in surface electromyography measurement

Veysel Alcan, Ersan Harputlu, Cumhur Gökhan Ünlü and 2 more

Biosensors and Bioelectronics: X · 2022

doi:10.1016/j.biosx.2022.100193 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Conventional silver-silver chloride (Ag/AgCl) electrodes are widely used for recording surface electromyography (sEMG) with a conductive gel. However, for long-term sEMG recording, the gel has some disadvantages that cause high impedance. Therefore, the dry electrodes have been alternatively purposed to overcome these disadvantages. Recently, the nanomaterial-based dry electrodes have been developed for long term electrophysiological signal recording. In the present study, we aimed to develop a graphene-coated Ag/AgCl electrode for long-term recording. We transferred single layer graphene (SLG) on the Ag/AgCl electrode surface by using chemical vapor deposition and confirmed this process by Raman scattering spectroscopy and scanning electron microscopy. We then compared the graphene-coated Ag/AgCl and conventional Ag/AgCl electrodes by evaluating median motor nerve conduction studies (mNCS) and their impedance. The charge transfer resistance (Rct) for the Ag/AgCl electrode (4170 Ω) was much higher than graphene-coated Ag/AgCl electrode (Rct = 24.6 Ω). For median mNCS measurements without gel, the graphene-coated Ag/AgCl electrode provided a better amplitude of distal and proximal compound muscle action potential (28.3 mV and 25.8 mV, respectively) than the Ag/AgCl electrode (21.8 mV and 20.9 mV, respectively). Consequently, the present study suggests promising results in terms of the usability of graphene-coated Ag/AgCl electrodes for long-term monitoring and wearable systems applications of sEMG. In future studies, we aim to investigate clinical applicability of graphene-coated sEMG electrodes that include extended clinical settings and larger study population.

Abstract licence: CC BY-NC-ND

References27

    27 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.